Abstract: A screening of marine bacteria for antimicrobial activity resulted in the isolation of Bacillus pumilus (SP21) from a sediment sample collected in the Bahamas. A bioassayguided fractionation led to the isolation of five surfactin analogs, glycocholic acid, amicoumacins A and B in addition to three new compounds named lipoamides A-C. The chemical structure of all the bioactive compounds was elucidated using spectroscopic methods including 2D NMR and MS. The antimicrobial activity of each compound was evaluated against a panel of pathogens and is reported herein.
INTRODUCTION
The need for antibiotics and antimicrobials continues to be a major challenge as infectious diseases affect millions of people worldwide. Further, antimicrobial resistance is a growing concern as the number of resistant bacteria and the geographic distribution of these organisms are both rising. Due to such global health concerns, our laboratory has been engaged in a program to identify natural products with activity against microbes. Marine-derived microorganisms have proven to be a useful source of such natural products and progress has recently been reviewed [1, 2] .
Bacteria of the genus Bacillus are known to produce natural products which possess antagonistic activities against many bacterial and fungal pathogens and are often used as agents for the treatment and/or prevention of different plant and animal infections [3] [4] [5] [6] . Their antimicrobial activities have mainly been attributed to the production of antibiotic peptide derivatives, lipopeptides [7] [8] [9] [10] , which have powerful surfactant like properties with numerous biotechnological applications including deemulsification, health care, and food industry. Moreover, in contrast with synthetic homologs, microbial surfactants are often biodegradable and can be supplied by fermentation [2, 11] . *Paper based on a presentation at the 26 th International Symposium on Chemistry of Natural Products (ISCNP-26) and 6 th International Conference on Biodiversity (ICOB-6), 13- 
RESULTS AND DISCUSSION

Bacterial isolation and screening for antimicrobial activity
During an expedition to the Bahamas in 2006, 445 bacterial strains from sediment samples were isolated. Extracts of all isolates were screened for antimicrobial activity against Staphylococcus aureus (ATCC 10832), Pseudomonas aeruginosa (ATCC 14210), and Candida albicans (ATCC 14053). From this screening, 41 showed antimicrobial activity against S. aureus, 4 (SP21, SPA3, VC2, and VC1) showed antimicrobial activity against P. aeruginosa, and 3 showed activity against C. albicans. All active strains were tested for antimicrobial activity against a second panel of microbes including Enterococcus faecalis (ATCC10741), Proteus vulgaris (ATCC 12454), and methicillin-resistant S. aureus (MRSA) (ATCC 33591). The activity in disk diffusion assays for the four isolates is summarized in Table 1 . SPA3, VC2, and VC1 showed some selectivity while SP21 was active against all strains tested. SP21 was identified by 16S rRNA sequence analysis as Bacillus pumilus and selected for chemical analysis. The surfactin analogs are composed of a heptapeptide fragment linked with an n-, iso-, or anteisohydroxy-fatty acid side chain with 13-16 carbons. In our case, tandem mass spectroscopy analysis allowed us to identify two different amino acid sequences among the various lipopeptides produced by B. pumilus (SP21). In order to evaluate the antimicrobial properties of these metabolites, the mixture was further purified by reverse-phase high-performance liquid chromatography (HPLC) with an isocratic mobile phase (75 % ACN in H 2 O with 0.1 % TFA) to lead to compounds 1 (6.9 mg), 2 (17.8 mg), 3 (2.5 mg), 4 (2.9 mg), and 5 (4.9 mg). In addition to the MS evidence, the 1 H NMR spectra for each compound was consistent with the previously reported lipopeptide structures [11, 12] .
Lipoamides A-C, amicoumacin and glycocholic acid derivatives
The supernatant extract was fractionated by C 18 flash chromatography, and three families of natural products were isolated by a series of HPLC purifications. Lipoamides A (6, 5.5 mg), B (7, 1.7 mg), and C (8, 1.8 mg) were isolated using a C 18 column with isocratic conditions (75 % MeOH in H 2 O with 0.1 % HCO 2 H). Compound 6, obtained as a colorless oil, was found to have the molecular formula C 15 13 C spectra to compound 6 and the only significant differences were molecular weight differences of 14 and 28 amu, respectively. Thus, the structures of lipoamides B (7) and C (8) are as shown in Table 3 .
Glycocholic acid (9, 7.7 mg) was readily isolated from the supernatant extracts by HPLC, and its structure was confirmed by comparison of 1D and 2D NMR data with that in the literature [13] . Compound 9 may be related to sterol derivatives present in the marine broth media and thus are believed to be produced through metabolism by B. pumilus SP21 during the fermentation process. A mixture of known amicoumacins was purified by HPLC using an isocratic system of 48 % MeOH in H 2 O with 0.1 % HCO 2 H leading to amicoumacin A (10, 5.4 mg) and amicoumacin B (11, 7.6 mg). Metabolites 10 and 11 were identified based on comparison of our spectroscopic data with that previously reported [14, 15] . 
Minimal inhibitory concentrations (MICs)
The MICs were evaluated for all isolated compounds and are summarized in Table 4 [16] . The lipopeptides, the most abundant secondary metabolites of the SP21 fermentation extract, showed the lowest MIC value with no significant difference between compounds 1-4. There is interesting selectivity with good activity against S. areus, P. vulgaris, and E. faecalis yet no activity against P. aeruginosa. Amicoumacin A (10) exhibited better antimicrobial activities than amicoumacin B (11), which may be due to the presence of an amide function at C-16. This report includes the first description of the activity of amicoumacin A against the "superbug" methicillin-resistant S. aureus (MRSA). Lipoamides showed no antimicrobial activity against S. aureus and P. aeruginosa with MIC values above 100 µg/ml.
F. BERRUE et al. (11) 50 >100 >100 50 n/a >100 Lipoamide A (6) >100 >100 n/a n/a n/a n/a Lipopeptide 1 6. In summary, new lipoamides isolated from B. pumilus have been reported for the first time. These were not found to exhibit significant antibacterial activity, however, the known lipopeptides and amicoumacins were found to exhibit selective antibacterial activity.
